DHGWA
TSVT

Dixon Hughes Goodman Wealth Advisors’s 2seventy bio TSVT Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5K Buy
+300
New +$5.09K ﹤0.01% 615

Other funds holding TSVT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's TSVT Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors opened a new position in 2seventy bio (TSVT) in Q1 2022: 300 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #615 among its holdings.

133 funds tracked by Wall St. Rank hold TSVT as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 300 shares of 2seventy bio worth $5K as of Q1 2022.
  • 2seventy bio was a new Dixon Hughes Goodman Wealth Advisors position in Q1 2022.
  • 2seventy bio made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #615 holding.
  • 133 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.